Collectively, congenital genitourinary (GU) birth defects are the most common birth defects in males, yet relatively little is known about their cause. In part, this reflects the current clinical perspective that, because most of these birth defects can be surgically repaired, there is nothing to be gained by understanding the cause. Accordingly, relatively little research has been performed until recently. Yet our studies suggest that seemingly simple birth defects like hypospadias or cryptorchidism, may be associated with other more significant underappreciated defects, such as those affecting the kidney, heart, eyes or behavior. Studies of chromosome microdeletions and microduplications (called copy number variations, CNVs) in GU individuals enabled us to test the hypothesis that gene-dosage changes in gene(s) encoded in CNV regions are important regulators of genitourinary development and when haploinsufficient or duplicated normal genitourinary development is impacted causing birth defects of the upper and/or lower genitourinary tract. We successfully used this strategy to identify 15 different previously unrecognized genes that when microduplicated or microdeleted result in conditions such as cryptorchidism, hypospadias, sexual ambiguity (disorders of sexual differentiation- DSD), congenital anomalies of the kidney and urinary track (CAKUT), as well as severe birth defects such as bladder exstrophy epispadias complex (BEEC). Causation was demonstrated through identification of the mechanisms involved and through re-capitulation of the birth defect with animal models of haploinsufficiency or over-expression. Remarkably, gene-dosage changes affected major signaling pathways and post-translational modifications in novel, previously unrecognized ways. In this proposal, we focus on defining the mechanisms of two candidate genes commonly microdeleted in patients with penile anomalies. We will test the hypothesis that RBFOX2 CNVs at 22q13.3 contribute to GU anomalies by producing alternate splice variants of FGFR2 (FGFR2IIIc instead of FGFR2IIIb) hindering penile growth and urethral development. The second hypothesis is that Kank1 deletion at 9p24.3 blunts ?-catenin regulation of FGF8 expression during genital tubercle development causing penile anomalies. These studies will not only identify previously unrecognized causes of GU anomalies but also additional, associated sequelae of these gene dosage changes. In the future, such knowledge may lead to improved diagnosis and therapeutic approaches to ameliorate these common birth defects.

Public Health Relevance

Parental joy at the birth of their child can quickly turn to dismay when a child is born with a congenital urogenital birth defect, such as hypospadias, renal agenesis or other abnormalities of the kidney or upper urinary tract, epispadias or cryptorchidism (which rank among the most common birth defects in males). The causes of these congenital anomalies are not understood. The studies proposed use novel and complementary approaches to define the causes of these birth defects to ultimately improve patient diagnosis, prognosis and treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK078121-10
Application #
9472107
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mendley, Susan Ruth
Project Start
2007-12-01
Project End
2021-11-30
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
10
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Urology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Haller, Meade; Mo, Qianxing; Imamoto, Akira et al. (2017) Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development. Proc Natl Acad Sci U S A 114:4981-4986
Bekheirnia, Mir Reza; Bekheirnia, Nasim; Bainbridge, Matthew N et al. (2017) Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene. Genet Med 19:412-420
Chiba, Koji; Ramasamy, Ranjith; Lamb, Dolores J et al. (2016) The varicocele: diagnostic dilemmas, therapeutic challenges and future perspectives. Asian J Androl 18:276-81
Gomez, Lissette; Kovac, Jason R; Lamb, Dolores J (2015) CYP17A1 inhibitors in castration-resistant prostate cancer. Steroids 95:80-7
Jorgez, Carolina J; Wilken, Nathan; Addai, Josephine B et al. (2015) Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia. Fertil Steril 103:44-52.e1
Kovac, Jason R; Rajanahally, Saneal; Smith, Ryan P et al. (2014) Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med 11:553-62
Jorgez, Carolina J; Rosenfeld, Jill A; Wilken, Nathan R et al. (2014) Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1. PLoS One 9:e107028
Kovac, Jason R; Pan, Michael M; Lipshultz, Larry I et al. (2014) Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids 89:27-32
Tannour-Louet, Mounia; Han, Shuo; Louet, Jean-Francois et al. (2014) Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action. Nat Med 20:715-24
Kovac, Jason R; Kovac, Jason; Pastuszak, Alexander W et al. (2014) Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad Med 126:149-56

Showing the most recent 10 out of 25 publications